Pre-Market Stock Futures: Futures are trading lower on Tuesday morning after investors returned from the three-day Easter weekend to find a stock market ready to rally after some promising news on the war in Iran and a sense, among some across the financial world, that the market had put in a new bottom. Ed Yardeni,... Here Are Tuesday's Top Wall Street Analyst Research Calls: Ameriprise Financial, Arista Networks, Arm Holdings, Lennar, Morgan Stanley, Rocket Lab, Tractor Supply, Wingstop, Wix.com and More
Allspring Global Investments Holdings LLC cut its holdings in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 4.1% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 129,211 shares of the medical research company's stock after selling 5,556 shares during the period.
HOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its fourth quarter (Q4'25) and year ended December 31, 2025 (2025) results. BIO-key will host an investor call today at 10:00am ET (details below).
KUALA LUMPUR, MALAYSIA, March 30, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. ("BGMS," the "Company" or “we,” formerly Cyclacel Pharmaceuticals, Inc.) (NASDAQ: BGMS), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced fourth quarter and full year 2025 financial results and provided a business update.
BKYI: Identity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tues., Mar 31 at 10am ET. Dial-in: 1-877-418-5460
AGOURA HILLS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today that its subsidiary Sapu Nano will formally introduce its Deciparticle™ nanomedicine platform and present its advancing clinical pipeline at BIO-Europe Spring 2026, where the company has been selected as a Presenting Company.
BERKELEY HEIGHTS, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company, announced today that Seth Lederman, MD, Chief Executive Officer, will deliver a company presentation at BIO-Europe Spring 2026, being held March 23-25, 2026, in Lisbon, Portugal.
HOLMDEL, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions enabling phoneless, tokenless, passwordless, and phishing-resistant authentication, today announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions), a leading technology partner to the U.S. public sector, to bring BIO-key's comprehensive suite of security solutions to federal, state, and local government agencies.
Fisher Asset Management LLC trimmed its stake in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 3.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 133,465 shares of the medical research company's stock after selling 4,277 shares during the period. Fisher Asset Management LLC owned about
Retail Bank Executes Expanded $1.04M License Renewal for BIO-key Biometric Identity Solution Serving 30M Clients, cash position provides base for growth.
